Suppr超能文献

在服用氯吡格雷的老年心肌梗死患者中,导致急性胃肠道出血的风险因素。

Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.

机构信息

Louis Stokes VA Medical Center, Cleveland, Ohio, USA.

出版信息

J Dig Dis. 2014 Apr;15(4):195-201. doi: 10.1111/1751-2980.12123.

Abstract

OBJECTIVE

Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.

METHODS

Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge.

RESULTS

Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs. 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs. 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs. 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs. 11.1%, P = 0.003), chronic liver (5.6% vs. 2.2%, P = 0.018) or kidney disease (29.0% vs. 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding.

CONCLUSIONS

Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding.

摘要

目的

本研究旨在确定出院后接受氯吡格雷治疗的心肌梗死(MI)患者发生急性胃肠道(GI)出血的危险因素。

方法

本研究回顾性收集了美国俄亥俄州退伍军人事务部医院 2001 年至 2008 年间收治的 MI (国际疾病分类第 9 版)初诊患者的数据,患者出院后 48 小时内开具了氯吡格雷处方。主要结局为出院后急性 GI 出血。

结果

3218 例患者中有 107 例发生急性 GI 出血。出血患者年龄较大(66.2 岁比 62.4 岁,P=0.0002),肾小球滤过率较低(74 毫升/分钟比 81 毫升/分钟,P=0.024),华法林处方使用率较高(15.9%比 6.9%,P=0.0004),诊断为心房颤动(20.6%比 11.1%,P=0.003),慢性肝脏(5.6%比 2.2%,P=0.018)或肾脏疾病(29.0%比 19.4%,P=0.016)。建立了风险模型和 GI 出血风险评分,结果显示,年龄>65 岁、使用华法林、存在慢性肝脏或肾脏疾病的患者发生 GI 出血的风险增加。

结论

年龄较大、使用华法林、患有慢性肝脏和肾脏疾病的退伍军人患者在 MI 后接受氯吡格雷治疗时,可能会增加 GI 出血的风险。评分系统有助于识别发生 GI 出血的高风险患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验